← Eichor
Study identifier: NCT05227924 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty

Condition: Degenerative Hip Joint Disease · Post-traumatic Osteoarthritis · Hip Arthritis  ·  Sponsor: Dedienne Sante S.A.S.

PhaseN/A
Planned participants747
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this post-market clinical follow up study is to assess the safety and effectiveness of the SYMBOL range of medical devices. The study will evaluate the outcome of Total Hip Arthroplasty using medical devices from SYMBOL range over a period of 10 years.

This description comes directly from the study's public registry record.

Talk to the study team

Marion Burland  ·  +33 (0)4 66 28 06 85  ·  reg.aff@dedienne-sante.com

Always discuss trial participation with your own doctor first.

Locations (9)

Hôpital Privé de la ChâtaigneraieBeaumont, FranceRecruiting
CH de Marmande - CHICMarmande, FranceTerminated
Hôpital Privé du Grand NarbonneMontredon-des-Corbières, FranceRecruiting
Polyclinique Grand SudNîmes, FranceRecruiting
Clinique Mutualiste CatalanePerpignan, FranceRecruiting
CH de PéronnePéronne, FranceRecruiting
Clinique MutualisteSaint-Etienne, FranceRecruiting
Hôpital d'Instruction des Armées Saint-AnneToulon, FranceRecruiting
Hôpital Robert Schuman - UNEOSVantoux, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05227924